European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Merck sp. z o.o., Warsaw, Poland

Watch
Merck sp. z o.o.

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €/month

Learn more
Learn more
View plans

Name

Merck sp. z o.o.

Identification

Krs
National Court Register KRS0000006628
Lei
529900KN395II4UJ6447
EUID
PLKRS.0000006628

Address

AL. Aleje Jerozolimskie 142B, 02-305 Warszawa, Poland

Corporate purpose

46.46
Wholesale of pharmaceutical goods
46
Wholesale trade, except of motor vehicles and motorcycles
70
Activities of head offices; management consultancy activities
71
Architectural and engineering activities; technical testing and analysis
72
Scientific research and development
73
Advertising and market research
74
Other professional, scientific and technical activities
77
Rental and leasing activities
96.09
Other personal service activities n.e.c.

Financial performance

History

Persons

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
1Managing Director
3Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
One known active shareholding
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Revenue
Revenue CAGR
Equity
Equity ratio
Taxes
Cash on hand
Receivables
Cost of materials
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2023 to 2024
Profit & Loss
from 2023 to 2024
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Publications

4 Sept 2026
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
4 Sept 2026
RDF51537195122
4 Sept 2026
Activity report
4 Sept 2026
Auditor's opinion
4 Sept 2026
Annual financial statement approval
4 Sept 2026
Activity report
4 Sept 2026
Auditor's opinion
4 Sept 2026
Annual financial statement approval
30 Jul 2026
CEO: Valeria Kyska
11 Jun 2026 via E. Merck KG also 26/05/2025, 21/05/2024, 06/04/2023, 22/04/2022, 26/04/2021, 09/06/2020, 08/04/2019, 09/04/2018, 11/04/2017, 03/06/2016, 23/05/2013, 25/04/2012, 10/05/2011, 27/10/2010, 04/05/2010, 28/04/2009
Shareholder: E. Merck KG
6 May 2026 via Merck KGaA also 28/05/2025, 05/08/2024, 20/09/2023, 17/04/2023, 23/05/2022, 06/05/2022, 02/05/2022, 09/06/2020, 08/06/2020, 21/05/2019, 10/04/2019, 23/05/2018, 08/05/2018, 22/05/2017, 04/04/2017, 19/07/2016, 06/06/2016, 01/06/2015, 29/04/2015, 25/06/2014, 22/05/2014, 03/06/2013, 29/05/2013, 03/05/2012 and 11 more
Shareholder: MERCK KGaA
24 Sept 2025
No longer CEO: Philip J. Krzyzek
30 Jun 2025
Annual financial statement approval
2 Jun 2025
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
2 Jun 2025
Auditor's opinion
2 Jun 2025
Activity report
14 Feb 2025
No longer Authorized signatory (ppa): Anna Muzyka
4 Oct 2024
Annual financial statement approval
23 Sept 2024
Activity report
24 Aug 2024
Auditor's opinion
19 Jul 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
28 Jun 2024
Annual financial statement approval
19 Jun 2024
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
19 Jun 2024
Auditor's opinion
19 Jun 2024
Activity report
4 Oct 2023
Annual financial statement approval
28 Sept 2023
Auditor's opinion
27 Sept 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
27 Sept 2023
Activity report
20 Sept 2023
Annual financial statement approval
15 Sept 2023
Auditor's opinion
12 Sept 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
12 Sept 2023
Activity report
30 Jun 2023
Annual financial statement approval
19 Jun 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
19 Jun 2023
Auditor's opinion
19 Jun 2023
Activity report
17 Apr 2023 via MERCK KGaA
Shareholder: MERCK KGaA
14 Dec 2022
Authorized signatory (ppa): Anna Muzyka
30 Sept 2022
Annual financial statement approval
29 Sept 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
29 Sept 2022
Auditor's opinion
29 Sept 2022
Activity report
31 May 2022
Annual financial statement approval
26 May 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
26 May 2022
Auditor's opinion
26 May 2022
Activity report
17 Mar 2022
Authorized signatory (ppa): Wojciech Bętkowski · No longer Authorized signatory (ppa) (1)
30 Sept 2021
Annual financial statement approval
20 Sept 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
20 Sept 2021
Auditor's opinion
20 Sept 2021
Activity report
20 Jul 2021 via Merck Life Science sp. z o.o.
Shareholding: Merck Life Science sp. z o.o
13 Jul 2021
Member of the Executive Board: Paweł Piwko · No longer Member of the Executive Board: Caroline C. Philippe
8 Apr 2021
Annual financial statement approval
25 Mar 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
25 Mar 2021
Auditor's opinion
25 Mar 2021
Activity report
27 Oct 2020
CEO: Philip J. Krzyzek · No longer CEO: Selen Z. Bisson
8 Oct 2020
Annual financial statement approval
8 Oct 2020
Res­o­lu­tion on profit dis­tri­b­u­tion or loss coverage
30 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
30 Sept 2020
Auditor's opinion
29 Sept 2020
Activity report
20 Sept 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
20 Sept 2019
Auditor's opinion
20 Sept 2019
Annual financial statement approval
20 Sept 2019
Activity report
3 Jun 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
3 Jun 2019
Auditor's opinion
3 Jun 2019
Res­o­lu­tion on profit dis­tri­b­u­tion or loss coverage
3 Jun 2019
Annual financial statement approval
3 Jun 2019
Activity report
31 Dec 2018
No longer Authorized signatory (ppa) (1)
10 Aug 2018
Annual report
10 Aug 2018
Annual report
10 Aug 2018
Annual report
10 Aug 2018
Annual report
10 Aug 2018
Annual report
10 Aug 2018
Auditor's opinion
10 Aug 2018
Annual financial statement approval
10 Aug 2018
Res­o­lu­tion on profit dis­tri­b­u­tion or loss coverage
10 Aug 2018
Activity report
14 Jun 2018
Annual report
14 Jun 2018
Annual report
14 Jun 2018
Annual report
14 Jun 2018
Annual report
14 Jun 2018
Annual report for the year ending 31/12/2017
14 Jun 2018
Auditor's opinion
14 Jun 2018
Res­o­lu­tion on profit dis­tri­b­u­tion or loss coverage
14 Jun 2018
Annual financial statement approval
14 Jun 2018
Activity report
5 Mar 2018
Address
7 Feb 2018
CEO: Selen Z. Bisson · No longer CEO: Michał Paweł Bichta
12 Jan 2018
Authorized signatory (ppa) (1)
17 Oct 2017
Member of the Executive Board: Caroline C. Philippe · No longer Member of the Executive Board: Rainer R. Raschke · No longer Authorized signatory (ppa) (1)
17 Oct 2017
No longer Authorized signatory (ppa) (1)
30 Dec 2016
Change of shareholdings: Sigma-Aldrich International GmbH · Capital: 29.7M PLN
16 Dec 2016 via Merck Life Science sp. z o.o.
Shareholding: Sigma - Aldrich sp. z o.o
14 Dec 2016
Authorized signatory (ppa): Joanna Bogdańska
23 Nov 2016
Shareholder: Sigma-Aldrich International GmbH · No longer Shareholder: Merck Internationale Beteiligungen GmbH
2 Nov 2016
No longer Authorized signatory (ppa) (1)
10 Oct 2016
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
1 Dec 2015
Authorized signatory (ppa) (1)
11 Sept 2015
No longer Authorized signatory (ppa) (1)
30 Jun 2015
Segment clas­si­fi­ca­tion
23 Oct 2014
Member of the Executive Board: Rainer R. Raschke
16 Sept 2014 via Merck Internationale Beteiligungen GmbH also 05/08/2013, 26/06/2012, 29/06/2011, 07/05/2010
Shareholder: Merck Internationale Beteiligungen GmbH
28 Aug 2014
No longer Member of the Executive Board (1)
17 Sept 2013
Authorized signatory (ppa) (1)
21 Mar 2013
Address
4 Mar 2013
No longer Member of the Executive Board (1)
20 Feb 2013
Authorized signatory (ppa) (2) · No longer Authorized signatory (ppa) (1)
20 Apr 2011
Member of the Executive Board (1) · No longer Member of the Executive Board (2)
29 Nov 2010
No longer Authorized signatory (ppa) (1)
30 Sept 2010
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1) · Segment clas­si­fi­ca­tion
31 Dec 2009
Shareholder: Merck Internationale Beteiligungen GmbH · No longer Shareholder: Merck AG
17 Mar 2008
Member of the Executive Board (3) · Authorized signatory (ppa) (1) · No longer Member of the Executive Board (1) · No longer Authorized signatory (ppa) (1)
4 Feb 2008
CEO: Michał Paweł Bichta · No longer Authorized signatory (ppa): Michał Paweł Bichta · No longer CEO (1)
7 Sept 2007
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
2 Aug 2007 via E. Merck KG
Shareholder: E. Merck OHG
12 Apr 2007
Authorized signatory (ppa) (1) · No longer Authorized signatory (ppa) (1)
29 Dec 2005
Authorized signatory (ppa): Iwona A. B. Robak
28 Apr 2005
No longer Authorized signatory (ppa) (2) · Authorized signatory (ppa) (2)
2 Mar 2005
Member of the Executive Board (1) · No longer Member of the Executive Board (1)
24 Aug 2004
Address
21 May 2003
Authorized signatory (ppa) (1)
5 Feb 2003
No longer Member of the Executive Board (1)
9 Jan 2003
CEO (1)
7 Nov 2002
Change of shareholdings: Merck AG
3 Oct 2002
Change of shareholdings: Merck AG · Capital: 12.5M PLN
9 Apr 2001
Reg­is­tra­tion: 09/04/2001 · Authorized signatory (ppa) (3) · Member of the Executive Board (2) · SH: Merck AG · Address · Capital: 12.5M PLN · Name: Merck sp. z o.o. · Segment clas­si­fi­ca­tion
There are no publications matching your search.

Mentions

21 Nov 2024 in Ler
Ultimate parent
25 Aug 2021 in Ler
Direct parent
9 Mar 2018 in Ler
No longer Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.